https://www.selleckchem.com/pr....oducts/tiragolumab-a
The newly developed bivalent ligands are excellent tools to further understand the pharmacological consequences of D2R homo- and heterodimerization. Not limited to the dopaminergic system, modifying class A GPCRs' dynamic equilibrium between monomers, homomers, and heteromers with bivalent ligands may represent a novel pharmacological concept paving the way toward innovative drugs.For dental impression of a prepared tooth, the goal is a void-free negative representation from which an accurate cast of a tooth and its surro
Like
Comment
Share
